The immunology of renal cell carcinoma | Nature Reviews Nephrology
Comprehensive molecular characterization of clear cell renal cell carcinoma | Nature
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Systemic Therapy for Metastatic Renal-Cell Carcinoma | NEJM
Molecular Imaging of Renal Cell Carcinoma in Precision Medicine | Molecular Pharmaceutics
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions - ScienceDirect
Renal cell carcinoma: the search for a reliable biomarker - Farber - Translational Cancer Research
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma | Nature Reviews Urology
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer - ScienceDirect
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Exosomes as a Multicomponent Biomarker Platform in Cancer: Trends in Cancer
IJTM | Free Full-Text | Non-Clear Cell Renal Cell Carcinoma: Molecular Pathogenesis, Innovative Modeling, and Targeted Therapeutic Approaches
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
Renal cancer biomarkers: the promise of personalized care | BMC Medicine | Full Text
Frontiers | Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
Biomarker discovery for renal cancer stem cells - Corrò - 2018 - The Journal of Pathology: Clinical Research - Wiley Online Library
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development | Journal of the American Chemical Society
How are biomarkers used to treat cancer? | MD Anderson Cancer Center
